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Abstract
Previous models of glycolysis in the sleeping sickness parasite Trypanosoma brucei assumed that 
the core part of glycolysis in this unicellular parasite is tightly compartimentalized within an 
organelle, the glycosome, which had earlier been shown to contain most of the glycolytic 
enzymes. The glycosomes were assumed to be largely impermeable, and exchange of metabolites 
between the cytosol and the glycosome was assumed to be regulated by specific transporters in the 
glycosomal membrane. This tight compartmentalization was considered essential for parasite 
viability. Recently, size-specific metabolite pores were discovered in the membrane of 
glycosomes. These channels are proposed to allow smaller metabolites to diffuse across the 
membrane but not larger ones. In light of this new finding, we reanalysed the model taking into 
account uncertainty about the topology of the metabolic system in Trypanosoma brucei, as well as 
uncertainty about the values of all parameters of individual enzymatic reactions. Our analysis 
shows that these newly discovered nonspecific pores are not necessarily incompatible with our 
current knowledge of the glycosomal metabolic system, provided that the known cytosolic 
activities of the glycosomal enzymes play an important role in the regulation of glycolytic fluxes 
and the concentration of metabolic intermediates of the pathway.
*rainer.breitling@manchester.ac.uk. 
Supporting information
Supplementary Doc: Detailed description of the added and modified rate equations, and the sampling of the parameters.
Fig S1: Glucose consumption flux in models without any activity of the glycolytic enzymes in the cytosol.
Fig S2: Glucose consumption flux in the impermeable model (Model 1a, no activity of the glycolytic enzymes in the cytosol) when 
the rate of the glycerol transporter is increased.
Fig S3: Examples of comparison between the distribution of parameter values as sampled and the same parameter in the 1% best 
parameter sets.
Fig S4: Distributions of the percentages of activity of the glycolytic enzymes in the cytosol among the top 1% of parameter sets of 
models 1a, 3 and 4.
Fig S5: Percentages of parameter sets allowing each model topology to reach steady-state before 1000 simulated minutes.
Table S1: Parameters significantly different in the best parameter sets (highest 1% log-likelihood) when compared to the other 99% 
sampled values.
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Introduction
The kinetic model of glycolysis in the sleeping sickness parasite Trypanosoma brucei was 
one of the first detailed kinetic models of metabolism for which measured enzyme kinetic 
parameters were used, rather than presumed [1]. The model postulated that the core part of 
glycolysis in this unicellular parasite is tightly compartmentalized within an organelle, the 
glycosome, which had earlier been shown to contain most of the glycolytic enzymes [2]. 
The glycosome was considered to be largely impermeable. Exchange of metabolites was 
assumed to be regulated by specific transporters in the glycosomal membrane. This 
assumption was supported by the experimentally validated model prediction that 
mislocalisation of glycolytic enzymes to the cytosol leads to a lethal accumulation of sugar 
phosphates in the cytosol [3, 4]. This encouraging agreement between modelling and 
experiment reinforced the conviction that leaky glycosomes would be incompatible with 
parasite physiology. Notwithstanding, arguments that the glycosome membrane should be 
considered only as semi-permeable were made [5].
Recently, size-specific metabolite pores were discovered in the membrane of the 
glycosomes [6]. These channels are proposed to allow smaller metabolites to diffuse freely 
across the membrane, but not larger ones. This observation adds support to the idea that 
glycosomes are not impermeable. In this paper, we show that these newly discovered 
nonspecific pores are not necessarily incompatible with our current knowledge of the 
glycosomal metabolic system provided that the known cytosolic activities of the glycosomal 
enzymes play an important role in the regulation of glycolytic fluxes and the concentration 
of metabolic intermediates of the pathway.
We do so by taking into account uncertainty about the topology of the metabolic system in 
T. brucei, as well as uncertainty about the values of all parameters of the enzymatic 
reactions [7]. Comparing different model topologies and taking parameter uncertainty into 
account reveals unexpected robustness to glycosome leakiness. The model also uncovers 
several major gaps in our current understanding of trypanosome glycolysis which should 
guide further experimentation towards a full description of this pathway in T. brucei.
The 14 different models are available in SBML format, with a tab-delimited file including 
100,000 parameter sets as they were sampled, at https://seek.sysmo-db.org/models/107.
Results and Discussion
A few methods for dealing with this uncertainty have been suggested before [8, 9, 10, 11, 
12]. In this context, we have previously analysed the existing model of T. brucei glycolysis 
taking into account uncertainty about the enzyme parameter values, but keeping the 
topology of the model fixed [7]. In addition, we incorporate a second tier of uncertainty into 
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the model with regard to its topology, i.e., considering which reactions occur, and in which 
subcellular compartment. Topological uncertainty is regularly dealt with in the context of 
genome-scale metabolic reconstructions (see for example [13]), but is usually disregarded in 
dynamic model analysis. For this purpose, we constructed alternative model versions with 
different topologies. We then simulated each model version using a large range of plausible 
parameter sets which were sampled from distributions reflecting our degree of uncertainty 
about each parameter (see [7] and Methods for details).
Exploring the effect of a permeable glycosome
In the original model published in 1997 and in all of its subsequent iterations [1, 14, 15, 3, 
16, 17, 7], the glycosomes have been considered to be impermeable (see Fig. 1). However, 
the recently discovered pores [6] would allow free diffusion of the smaller metabolites 
between the cytosolic and the glycosomal lumen. This has been considered to be 
incompatible with the survival of the parasite, due to the accumulation of sugar phosphates 
observed when the glycosomal enzymes are mislocalised to the cytosol and therefore 
exposed to a high ATP/ADP ratio. This phenomenon, referred to as a “turbo explosion”, is 
assumed to result from the loss of specific regulatory feedbacks for critical enzymes [3, 4]. 
Consequently, after the discovery of unspecific pores, mechanisms that would nonetheless 
permit all metabolites to be retained inside the glycosomes have been hypothetised, but no 
evidence for any of them has been found [18]. Here, we explore the consequences of 
increasing the permeability of glycosomes in a series of alternative computational models 
and reveal an important role for residual cytosolic activities of several glycolytic enzymes 
whose function had hitherto been unclear.
To represent our uncertainty about the permeability of the glycosome, we constructed 
different versions of the model in which different groups of metabolites can freely diffuse 
across the glycosomal membrane. We defined the different groups of metabolites based on 
their molecular weight (see Figure 2). Based on these groups and on the last published 
version of the model [7] (which we updated by explicitly including glycerol transporters, see 
Methods and Supplementary Doc S1 for details), we built seven different model versions, 
each permitting an increasingly large set of metabolites to diffuse freely.
Among these seven models, we included two versions of the original impermeable model: 
model 1a, in which the transport of glycerol 3-phosphate and dihydroxyacetone phosphate is 
linked via an antiporter in the glycosomal membrane, as introduced in 1999 [14], and model 
1b, in which the transport of glycerol 3-phosphate and dihydroxyacetone phosphate is 
independent, as was the case in the first published version of the model in 1997 [1]. The 
glycerol 3-phosphate/dihydroxyacetone phosphate antiporter was introduced to lower the 
effect of the inhibition of the glucose consumption flux by glycerol, thus allowing a better 
agreement of the model with experimental results [14]. Therefore, we expect model 1a (with 
antiporter) to perform better than model 1b (without). Experimental evidence for the 
antiporter is lacking. However, the requirement for such a transporter disappears if glycerol 
3-phosphate and dihydroxyacetone phosphate are able to diffuse using the newly identified 
permeability pores. Therefore, it is important to evaluate the effect on model behaviour of 
the replacement of the specific antiporter by diffusion pores.
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Since exposing the glycosomal enzymes to the ATP/ADP ratio of the cytosol leads to a 
“turbo explosion” when cells are exposed to high concentrations of external glucose [4], we 
know that at least model 6 (which allows ATP and ADP to diffuse freely) should show this 
lethal increase in sugar-phosphate concentrations when the external glucose concentration is 
high. We simulated all model versions at both 5 and 50 mM of glucose in the medium and in 
both aerobic and anaerobic-like conditions. In our model, the anaerobic case was simulated 
by including an inhibitor (Salicylhydroxamic Acid or SHAM) of the trypanosomal 
glycerophosphate oxidase system (GPO, the only oxygen-using reaction in the model which 
covers two reactions in vivo: glycerol 3-phosphate and trypanosome alternative oxidase), in 
order for our simulation process to remain as close to the experimental setting as possible 
(see Supplementary Doc S1 for details).
Under aerobic conditions (see Figure 3 A and B), most models lead to similar predictions for 
the glucose consumption flux. Only model 4 (in which glycosomes are permeable to all 
metabolites other than AMP, ADP, ATP, NAD and NADH) and model 5 (similar to model 
4, but where glycosomes are also permeable to AMP) show lower fluxes for some parameter 
sets. It has been shown that the parasite dies when the glucose consumption flux is inhibited 
more than 50% [19], therefore models 4 and 5 are not compatible with experimental data for 
some parameter sets. In anaerobic conditions, however, all models show lower glucose 
consumption fluxes than in aerobic conditions, except for model 6 (in which glycosomes are 
permeable to ADP and ATP). Models 1b, 2, 3, 4 and 5 (which are models with increasingly 
permeable glycosomes) show significantly lower fluxes than model 1a (the impermeable 
model with a glycerol 3-phosphate/dihydroxyacetone phosphate antiporter). Hence, the 
absence of the antiporter is sufficient to render the performance of the impermeable model 
as poor as the semi-permeable models (models 2 to 5). Model 6 is the only one to show a 
similar distribution of glucose consumption fluxes in all conditions (see figure 3), which is 
consistent with experimental data [20, 15]. However, model 6 shows a dramatic increase in 
the intracellular sugar phosphate concentrations, especially at higher glucose concentrations, 
corresponding to the expected “turbo explosion” phenomenon which would be lethal in vivo 
(see the example of fructose 1,6-bisphosphate concentration in Figure 4), hence model 6 is 
not a realistic description of intact trypanosomes, as expected.
From these results, the model in which the glycosome is impermeable with a glycerol 3-
phosphate/dihydroxyacetone phosphate antiporter (model 1a), allows the best match 
between experimental results and simulations. However, the discovery of non-specific 
metabolite pores in the glycosomal membrane and the absence of experimental evidence for 
the antiporter means that a dilemma remains. Moreover, model 1a is inconsistent with 
several other facts. Most importantly, all parameter sets result in a lower glucose 
consumption flux in anaerobic conditions than in aerobic conditions, which is contrary to 
experimental observations [20, 15]. Model 1a did not show any decrease in glucose 
consumption flux in anaerobic conditions in previous versions of the model. Indeed, in 
earlier versions, the glycerol concentration was fixed to zero inside the glycosome, which 
means that the transport of glycerol outside was considered infinitely fast and the glycerol 
concentration outside as infinitely low. Both of these assumptions are unrealistic. When 
introducing the glycerol transporter, even considering that the transport can favour glycerol 
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export over import and setting its Vmax up to more than twice as fast as the measured Vmax, 
some inhibition of glucose consumption already appears with a very small concentration of 
glycerol outside the cell (see Supplementary Figure S1). Even when the glycerol transporter 
Vmax is increased to much higher values (up to 1000 nmol/min/mg of cell protein, which is 
10 times the rate of the glucose transporter), glucose consumption is still predicted to be 
lower in anaerobic conditions (see Supplementary Figure S2).
In addition, model 1a neglects the need for glucose 6-phosphate and fructose 6-phosphate in 
the cytosol. Indeed, previous versions of the model also assumed that the glycosomal 
enzymes have no activity in the cytosol. However, several glycolytic metabolites are 
required in the cytosol as input to other pathways, for example, glucose 6-phosphate for the 
cytosolic branch of the pentose phosphate pathway [21] or fructose 6-phosphate for the 
synthesis of fructose 2,6-bisphosphate [22]. These metabolites either come from the 
glycosome or are synthesised directly in the cytosol, implying the presence of some 
glycolytic enzymes in the cytosol. Moreover, it has been known for many years that specific 
isoforms are present for key enzymes including glyceraldehyde phosphate dehydrogenase 
(GAPDH). The glycosomal enzymes are imported fully folded and functional [23, 24]. 
Therefore, even when specific cytosolic isoforms have not been identified, activity of the 
freshly synthesized enzymes, prior to their entry into the glycosomes, will be found in the 
cytosol.
Exploring the effect of specific or residual activity of the glycosomal enzymes in the 
cytosol
Uncertainty pertaining to the topology of the model means that some fraction of activity of 
the glycosomal enzymes in the cytosol should be included. Data about the percentage of 
activity in the cytosol is very limited except for glyceraldehyde-3-phosphate dehydrogenase, 
which is present in the cytosol as the product of a different gene than that encoding the 
glycosomal version (see Supplementary Doc S1). Although measurements of these fractions 
have been attempted [2, 25], the fragility of glycosomes and the properties of some enzymes 
(such as the tendency of hexokinase to stick to membranes [26]) have precluded any reliable 
quantification. We assumed, however, that the percentage of cytosolic activity of these 
enzymes is probably small, and certainly more than 50 percent of each of these enzymes is 
in the glycosomes. Therefore, percentages were sampled from a log uniform distribution 
between 0.01% and 50% (using a log uniform distribution allows each order of magnitude to 
be sampled in similar proportions, and also ensures that the unlikely very high values are 
only rarely sampled; 80% of the values will be < 5%; see Supplementary Doc S1 for 
details).
Figure 5A and B show that most models with an explicit fraction of cytosolic activity of 
glycolytic enzymes have similar distributions of glucose consumption flux under aerobic 
conditions, with only a small proportion of some models with some sampled parameter sets 
showing a drop in flux that differs from experimental observations. However, under 
anaerobic conditions (Figure 5C and D), models 3, 4 and 5 (which have glycosomes 
permeable to metabolites smaller than, respectively, fructose 6-phosphate, fructose 1,6-
bisphosphate and AMP) allow higher glucose consumption fluxes at both 5 and 50 mM of 
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glucose than when cytosolic activities of the glycolytic enzymes was not considered (Figure 
3). Therefore, introducing a fraction of cytosolic activity of the glycolytic enzymes allows 
models with semi-permeable glycosomes to simulate experimental data, i.e. fluxes and 
metabolite concentrations, much better than when the cytosolic fraction is ignored. We went 
on to test whether these higher fluxes are always associated with lethal accumulation of 
sugar phosphates at 50 mM of glucose in aerobic conditions. Figure 6B shows that in both 
aerobic and anaerobic conditions, most parameter sets do indeed lead to an increased 
fructose 1,6-bisphosphate concentration compared to the same model without any glycolytic 
activity in the cytosol (Figure 4). As expected, model 6 still shows a dramatic increase in 
fructose 1,6-bisphosphate. This shows that adding cytosolic activity of the glycolytic 
enzymes can allow the glucose consumption flux to be higher anaerobically, but that some 
of these parameter sets lead to an increase of the sugar phosphate concentrations, sometimes 
up to several hundreds of millimolar. To better simulate experimental observation, a model 
should allow both higher fluxes and avoid these accumulations of sugar phosphate. 
Therefore, to be able to know which model is the most realistic, every model and every 
parameter set needs to be evaluated by comparing its simulated results with all experimental 
data available (metabolite concentrations and fluxes).
However, matching experimental data of this complexity to model predictions offers great 
challenges, since some aspects of the metabolic phenotype can match experimental results 
while, simultaneously, others do not. To quantify the match between the models and the 
experimentally measured concentrations and fluxes, we computed log-likelihoods for each 
model and for each parameter set. These log-likelihoods are computed by comparing the 
simulated values of the whole-cell metabolite concentrations and fluxes to distributions 
based on a wide range of experimental data. These distributions represent our (uncertain) 
knowledge of the intracellular metabolite concentrations, the glucose consumption flux, and 
the glycerol production flux relative to the pyruvate production flux in both aerobic and 
anaerobic conditions, at 50 mM of external glucose (which is the concentration of glucose 
used in the experiments measuring the intracellular metabolite concentrations; see Methods 
for details). The higher the log-likelihood (closer to zero), the better the match is between 
model prediction and experimental data.
The distributions of the log-likelihoods for each model topology are shown in Figure 7. As 
expected, model 6 never performs as well as the best models. Indeed, since ATP and ADP 
can diffuse freely in this model, the model is less sensitive to the proportion of activity of 
the glycosomal enzymes in the cytosol. The models that allow the highest log likelihood 
(Figure 7) for the largest number of parameter sets are models 3 and 4 (the models with 
glycosomes permeable to small metabolites up to the size of fructose 6-phosphate and 
fructose 1,6-bisphosphate respectively). This shows that, based on our current knowledge, 
permeable models can yield matches to the experimental data that are equally good as the 
original model that depends on an impermeable membrane.
Identification of the best parameter sets for each model topology
It is striking that no matter which topology we preferred, there is always a large fraction of 
perfectly plausible parameter sets that lead to highly unlikely model predictions. We aim to 
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exploit this observation to update our beliefs about the most likely parameter values. Using 
the log-likelihoods, we tested whether the top performing 1% of parameter sets for each 
model have significantly different parameter values compared to the other parameter sets. 
The results are shown in Table 1 (selected Vmax only) and Supplementary Table S1 (see 
Supplementary Figure S3 for two examples and Supplementary Figure S4 for the 
distribution of the proportion of activities in the top 1% of parameter sets). Indeed, the best 
matches to experimental data tend to occur for particular choices of parameters, and some of 
these are similar for all model topologies. First, the phosphoglycerate mutase (PGAM) Vmax 
is usually higher in the best 1% of parameter sets for all models. This is expected, since 
previous analyses showed that decreasing this parameter leads to an accumulation of 3-
phosphoglycerate [7]. The top 1% of parameter sets for all models also tend to have glucose 
transporter activity close to the minimal plausible value, allowing a flux of about 100 
nmol/min/mg of cell protein (see Supplementary Figure S3A). The effect of this reduction in 
transporter activity is to lower the concentration of free glucose in the cytosol, thus limiting 
the concentration of glucose 6-phosphate that would accumulate due to cytosolic 
hexokinase. This limited activity of the transporter is also in agreement with the finding that 
the glucose transporter has a significant control over the glucose consumption flux [14]. The 
fraction of parameter sets that allows the models to reach steady state is close to 100% for 
most model topologies (See Supplementary Figure S5).
Also common to all models, the glycerol transporter Vmax is usually set to higher values in 
the best parameter sets, so that glycerol is rapidly exported. This relates to the best models 
being those whose flux in anaerobic conditions is higher, hence where the inhibition of the 
flux by intracellular glycerol is the lowest. Under anaerobic conditions, for one mole of 
glucose consumed, one mole of glycerol and one mole of pyruvate are produced. This exact 
stoichiometric match is due to the fact that for each glucose consumed, two ATP molecules 
are used in the glycosomes (by hexokinase and phosphofructokinase); this ATP needs to be 
recovered by phosphoglycerate kinase (pyruvate branch) and glycerol kinase (glycerol 
branch). However, since the glycerol kinase equilibrium strongly favours ATP consumption 
using glycerol as its substrate, even a little accumulated glycerol inhibits ATP production. 
Indeed, it has been shown that addition of glycerol under anaerobic conditions kills the 
parasites, while without addition of external glycerol the glucose consumption flux in 
aerobic and anaerobic conditions is similar [27, 28, 29]. This inhibitory effect can be 
reduced by the increase of glycerol export, while also increasing the fraction of glycerol 
kinase in the glycosome. This also explains that the glycerol kinase Vmax is higher in the 
glycosome of the top 1% of parameter sets of each model.
A particularly surprising observation is the fact that models 1 to 3 favour having a higher 
proportion of aldolase activity in the cytosol in the best 1% of parameter sets: there seems to 
be no intuitive reason why the level of aldolase activity would lead to reduced accumulation 
of sugar-phosphates (including fructose 1,6-bisphosphate). The fraction of aldolase in the 
cytosol seems to be important, as long as fructose 1,6-bisphosphate cannot be transported 
across the glycosomal membrane. The fraction of hexokinase in the cytosol of the top 1% of 
parameter sets is also different depending on the model topology. In the best parameter sets 
of model 1a, 1b and 6 it is relatively small (the median value is about 4 nmol· min−1·(mg of 
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cell protein)−1 for model 1a, 9 nmol· min−1·(mg of cell protein)−1 for models 1b and 6, see 
Supplementary Table S1) while in models 2, 3 and 5 it is higher (the median value is 40 
nmol· min−1·(mg of cell protein)−1 for model 2, 53 nmol· min−1·(mg of cell protein)−1 for 
model 3 and 190 nmol· min−1·(mg of cell protein)−1 for model 5; model 4 shows no 
significant difference in cytosolic hexokinase activity between the top 1% of parameter sets 
and the other parameters sets: the median value of all parameter sets is about 13 nmol· 
min−1·(mg of cell protein)−1). However, the highest cytosolic hexokinase Vmax values never 
lead to a good match with the experimental data (see Supplementary Figure S3B). 
Differences are also observed for phosphoglycerate kinase, which is significantly higher in 
the cytosol of the best parameter sets of model 1a and 3 to 5 but lower in models 2 and 6. 
Additionally, glyceraldehyde phosphate dehydrogenase (GAPDH) activity in the cytosol is 
also significantly higher in the top 1% of parameter sets of models 1a, 3 and 4. Therefore, 
the best model topologies (models 1a, 3 and 4) seem to favor a higher flux in the cytosolic 
branch of the lower part of glycolysis (producing 3-phosphoglycerate from glyceraldehyde 
3-phosphate). Such a topology could allow these models to compensate for the loss of bound 
phosphates in the glycosome due to the the leakiness of the glycosomal membrane (model 3 
and 4). This may seem inconsistent with experiments that previously showed [30] that 
expressing the cytosolic version of phosphoglycerate kinase in bloodstream form parasite 
causes cell death, even for a low level of expression. However, in those experiments no 
difference in metabolite concentration or flux related to glycolysis could be measured in the 
overexpressing lines, and a general toxicity effect could not be excluded [30].
Many other parameters are distributed differently, depending on the model, and could 
potentially be used to design discriminatory experiments to decide in favor of one or the 
other topology, should the necessary measurement technology become available. For 
example, the triose phosphate isomerase (TPI) Vmax in the cytosol is significantly different 
for the best 1% of all models except models 2 and 5. Higher cytosolic TPI Vmax values are 
favoured for model 1a (the impermeable model with antiporter) but lower values are 
favoured for models 1b (no antiporter) to 6. This suggests that the free diffusion of 
dihydroxyacetone phosphate and glycerol 3-phosphate makes models sensitive to the 
presence of TPI in the cytosol. It has been shown that overexpressing this enzyme in the 
cytosol kills the parasite. However, the overexpression was important and, as is the case for 
PGK, the cause of the death of the cells with overexpression of TPI was not established, and 
a toxic effect of the overexpression per se (in contrast to a mere mis-targeting) could not be 
excluded. Establishing how sensitive trypanosomes are to the expression of TPI, and other 
glycosomal enzymes, in the cytosol and what the associated metabolic changes are, would 
be valuable information to help establishing which of our models is the closest 
mechanistically correct representation of the biological system.
Conclusion
We have shown, using mathematical modelling, that glycosomes do not need to be 
impermeable to explain glycolysis in trypanosomes. There is no need to hypothesize 
additional mechanisms to keep metabolites inside the glycosomes if a regulated proportion 
of glycolytic enzyme activity is found in the cytosol. The modelling results, based on an 
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explicit representation of parameter and topology uncertainty, point to key experiments that 
will help to determine the exact level of permeability of the glycosomes.
Methods
Model
The starting point for all models in this paper is the last updated version [7] of the glycolysis 
model of T. brucei first published by Bakker et al. in 1997 [1]. See Supplementary Doc S1 
for modifications and additions.
The 14 different models are available in SBML format, with a tab-delimited file including 
100,000 parameter sets as they were sampled, at https://seek.sysmo-db.org/models/107. See 
Supplementary Doc S1 for details.
Sampling of parameters
The parameters already present in the previous version of the model are sampled as in [7]. 
See Supplementary Doc S1 for details about the modifications, the sampling of the newly 
introduced parameters and the simulations.
Log-Likelihood
To compute the log-likelihood of each parameter set for each model, we first defined 
probability distributions representing our beliefs about the whole-cell metabolite 
concentrations and fluxes based on experimental data. Then, for each parameter set and for 
each model, the predicted steady-state concentrations and fluxes are compared to these 
distributions to compute the log-likelihood of each parameter set given our belief about the 
true concentrations and fluxes. See Supplementary Doc S1 for details.
Statistical tests
The parameters of the 1% best models were compared to the other parameters sets using the 
Mann-Whitney U test and the false discovery rate was controlled using the Benjamini-
Hochberg procedure (with α = 5%).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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PGK Phosphoglycerate kinase
SHAM Salicylhydroxamic Acid
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Figure 1. 
Aerobic glycolysis in bloodstream form T. brucei. Abbreviations: Metabolites: Glc-6-P = 
Glucose 6-phosphate, Fru-6-P = Fructose 6-phosphate, Fru-1,6-BP = Fructose 1,6-
bisphosphate, DHAP = dihydroxyacetone phosphate, GA-3-P = glyceraldehyde 3-
phosphate, Gly-3-P = glycerol 3-phosphate, 1,3-BPGA = 1,3-bisphosphoglycerate, 3-PGA = 
3-phosphoglycerate, 2-PGA = 2-phosphoglycerate, PEP = phosphoenolpyruvate. Reactions: 
1 = transport of glucose across the cytosolic membrane, 2 = transport of glucose across the 
glycosomal membrane, 3 = hexokinase, 4 = phosphoglucose isomerase, 5 = 
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phosphofructokinase, 6 = aldolase, 7 = triosephosphate isomerase, 8 = glyceraldehyde 3-
phosphate dehydrogenase, 9 = phosphoglycerate kinase, 10 = transport of 3-PGA across the 
glycosomal membrane, 11 = phosphoglycerate mutase, 12 = enolase, 13 = pyruvate kinase, 
14 = transport of pyruvate across the cytosolic membrane, 15 = glycerol 3-phosphate 
dehydrogenase, 16 = glycerol kinase, 17 = DHAP-Gly-3-P antiporter, 18 = glycerol-3-
phosphate oxidation, 19 = ATP utilisation, 20 = adenylate kinase, 21 = glycosomal glycerol 
transporter, 22 = cytosolic glycerol transporter.
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Figure 2. 
Definition of the different types of models based on the size of metabolites that can be 
transported across the glycosomal membrane. Model 1a and 1b differ by the nature of the 
transport of glycerol 3-phosphate and dihydroxyacetone phosphate. In model 1a, their 
transport is linked via an antiporter, as introduced in 1999 [14], while in model 1b they are 
transported independently, as was the case in the original model of 1997 [1].
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Figure 3. 
Glucose consumption flux in models with increasing glycosome permeability. (A, B) 
Aerobic conditions (−SHAM); (C,D) Anaerobic-like conditions (+SHAM). (A, C) 5 mM of 
external glucose; (B,D) 50 mM of external glucose. The glucose consumption flux is lower 
in anaerobic conditions than in aerobic conditions for all models, and more so for the 
permeable models, which is in contradiction with experimental results.
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Figure 4. 
Fructose 1,6-biphosphate concentration in models with increasing glycosome permeability. 
(A, B) Aerobic conditions (−SHAM) (C,D) Anaerobic-like conditions (+SHAM) (A, C) 5 
mM of external glucose, (B,D) 50 mM of external glucose; the vertical grey line indicate the 
average concentration of fructose 1,6-bisphosphate as measured by Visser and Opperdoes et 
al. [31]. All models maintain realistic concentrations except model 6 which accumulated 
fructose 1,6-bisphosphate in all conditions, but more importantly at 50 mM of external 
glucose.
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Figure 5. 
Glucose consumption flux in models with increasing glycosome permeability and cytosolic 
activities of the glycosomal enzymes. The distributions shown include all sampled fractions 
of cytocolic activities of the glycosomal enzymes for each model topology. (A, B) Aerobic 
conditions (−SHAM) (C,D) Anaerobic-like conditions (+SHAM) (A, C) 5 mM of external 
glucose, (B,D) 50 mM of external glucose. More models allow a similar flux in both aerobic 
and anaerobic conditions when a fraction of cytosolic activity of the glycosomal enzymes is 
included in the model (compare with Figure 3).
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Figure 6. 
Fructose 1,6-bisphosphate concentration in models with increasing glycosome permeability 
and cytosolic activities of the glycosomal enzymes. The distributions shown include all 
sampled fractions of cytocolic activities of the glycosomal enzymes for each model 
topology. (A, B) Aerobic conditions (−SHAM); (C,D) Anaerobic-like conditions (+SHAM). 
(A, C) 5 mM of external glucose; (B,D) 50 mM of external glucose; the vertical grey lines 
indicate the average whole-cell concentration of fructose 1,6-bisphosphate as measured by 
Visser and Opperdoes et al. [31]. When a fraction of cytosolic activity of the glycosomal 
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enzymes is included in the models, all model topologies have parameter sets that lead to the 
accumulation of high concentrations of fructose 1,6-bisphosphate. Hence, if glycosomal 
enzymes have a fraction of activity in the cytosol, it is probably regulated.
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Figure 7. 
Log-likelihood of models with increasing glycosome permeability and cytosolic activities of 
the glycosomal enzymes. The distributions shown include all sampled fractions of cytocolic 
activities of the glycosomal enzymes for each model topology. Inserts on the right show the 
fraction of parameter sets leading to a log-likelihood higher than −100 (top) higher than −30 
(bottom) for each model topology. The best parameter sets produces the largest log-
likelihoods (closer to 0), hence the models producing the closest match to experimental data 
are model 1a (impermeable with antiporter), 3 (permeable up to fructose 6-phosphate) and 4 
(permeable up to fructose 1,6-bisphosphate).
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Table 1
Fold-change of the median maximal activities significantly different in the best parameter 
sets (highest 1% log-likelihood) when compared to the other sampled values
Columns represents the different model topologies. See Supplementary Table S1 for all results. The fold-
changes are computed as the median value of the best sets over the median value of all sets. When the fold-
change is smaller then 1 (the parameter values are smaller in the best sets as compared to all sets) then −1/
Fold-change is displayed. The value is missing when the difference between the best parameter values and all 
parameter values is not statistically significant (Mann-Whitney U test, see Methods).
Reaction 1a 1b 2 3 4 5 6
PGAMc 1.1 1.0 1.1 1.1 1.1 1.1 1.0
GlcTc −1.1 −1.1 −1.1 −1.2 −1.2 −1.2 −1.2
GlyTc 1.3 1.1 1.1 1.2 1.2 1.1 1.2
GKg 1.2 1.1 1.1 1.1 1.1 1.1 1.1
ALDc 4.5 9.0 14.4 9.4 −2.0
HXKc −3.5 −1.5 3.0 4.1 14.4 −1.5
PGKc 2.3 −1.8 4.6 2.3 11.9 −1.8
GAPDHc 1.2 −1.1 −1.1 1.1 1.1 −1.2
TPIc 1.9 −1.6 −1.5 −1.4 −2.8
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